Isis Pharmaceuticals (ISIS -1.5%) announces the publication of two papers in the journal Cell...

|By:, SA News Editor

Isis Pharmaceuticals (ISIS -1.5%) announces the publication of two papers in the journal Cell demonstrating that single-stranded short interfering RNA molecules distributed broadly, activated the RNA interference pathway and selectively inhibit the expression of a targeted gene in animal models. The stock is down today however, largely due to technicals after re-testing but failing to break through its 52-week high late yesterday.